Ken Shiozawa
- Oncology top 5%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 5%
- Surgery
- Infectious Diseases top 10%
- Co-authors
- Hiroshi SodaKatsumi NakatomiShigeru KohnoMikio OkaDouglas D. RossYoji IkegamiShigeru KawabataTakeo Nakanishi
- Topics
- Drug Transport and Resistance Mechanisms (9 papers)Cancer therapeutics and mechanisms (7 papers)Histone Deacetylase Inhibitors Research (5 papers)
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ken Shiozawa
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Oncology 861
- Molecular Biology 687
- Pediatrics, Perinatology and Child Health 196
- Surgery 174
- Infectious Diseases 171
Countries citing papers authored by Ken Shiozawa
This map shows the geographic impact of Ken Shiozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Shiozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Shiozawa more than expected).
Fields of papers citing papers by Ken Shiozawa
This network shows the impact of papers produced by Ken Shiozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Shiozawa. The network helps show where Ken Shiozawa may publish in the future.
Co-authorship network of co-authors of Ken Shiozawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Shiozawa. A scholar is included among the top collaborators of Ken Shiozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Shiozawa. Ken Shiozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 65 | |
| 4 | 54 | |
| 5 | 53 | |
| 6 | BCRP expression is functionally upregulated by epidermal growth factor receptor (EGFR, ErbB1) mediated signaling in human ovarian cancer cell lines, but not in human breast cancer cell lines | 3 |
| 7 | 35 | |
| 8 | 126 | |
| 9 | 32 | |
| 10 | 149 | |
| 11 | 99 | |
| 12 | 36 | |
| 13 | Expression and functional analyses of breast cancer resistance protein in lung cancer. | 80 |
| 14 | 7 | |
| 15 | 161 | |
| 16 | 67 | |
| 17 | 30 | |
| 18 | 198 | |
| 19 | 27 | |
| 20 | 29 |
About Ken Shiozawa
Ken Shiozawa is a scholar working on Oncology, Gastroenterology and Molecular Biology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Cancer therapeutics and mechanisms (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Oncology (861 citations), Molecular Biology (687 citations) and Pediatrics, Perinatology and Child Health (196 citations). Ken Shiozawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Hiroshi Soda, Katsumi Nakatomi, Shigeru Kohno, Mikio Oka, Douglas D. Ross, Yoji Ikegami, Shigeru Kawabata, Takeo Nakanishi, Bret A. Hassel and Megumi Yoshikawa. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.